New horizons for therapeutics in drug and alcohol abuse

Pharmacology & Therapeutics
Bianca Jupp, Andrew J Lawrence

Abstract

Alcohol, tobacco and illicit drug dependence represents a serious health and social issue within the community. As drug dependence has become more widely recognized as a clinical disorder and the severity of the problem been fully realized, options available for treatment have grown along with our understanding of the neurobiological mechanisms underlying the development and persistence of addiction. Treatment has progressed from purely social and behavioral approaches to now encompass pharmacotherapy to attempt to disrupt the mechanisms underlying these disorders. Despite these advances, many forms of addiction lack effective therapeutics and the prevalence of this disorder remains unacceptably high. As a result, a significant effort within the research community has been dedicated to the identification of novel targets for the development of therapeutics based upon our understanding of the pathological processes underlying addiction. The current review aims to provide an overview of existing and clinically trialed pharmacotherapies for alcohol, opiate, psychostimulant, nicotine, cannabis and inhalant addictions. Further, we discuss some of the potential targets that have been recently indentified from basic studies that may h...Continue Reading

References

Jan 1, 1977·Journal of Studies on Alcohol·T M Kitson
Aug 1, 1977·British Journal of Pharmacology·A CowanI R Macfarlane
Apr 1, 1979·Biochemical Pharmacology·A E Felner, P C Waldmeier
Jan 1, 1992·The American Journal of Drug and Alcohol Abuse·J A HalikasR Crosby
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R SpanagelT S Shippenberg
Feb 18, 1991·The Medical Journal of Australia·E M Chalmers
Jan 1, 1991·Journal of Addictive Diseases·R D CrosbyG Carlson
Feb 11, 1992·Archives of Internal Medicine·D E HillemanM H Sketch
Jan 1, 1991·Psychopharmacology·W A Corrigall, K M Coen
Jan 1, 1991·Psychopharmacology·H A BaldwinK T Britton
Jan 1, 1990·Journal of Psychiatric Research·M FavaL Pill
Jan 1, 1990·Pharmacology, Biochemistry, and Behavior·M HaraguchiG A Tolliver
Jan 1, 1990·Annals of the New York Academy of Sciences·D S CharneyG R Heninger
Dec 1, 1989·British Journal of Pharmacology·A BoursonP C Moser
Feb 1, 1989·Archives of General Psychiatry·F H GawinC Morgan
Mar 18, 1989·Lancet·J HalikasF Crea
May 30, 1989·European Journal of Pharmacology·E CarboniG Di Chiara
Nov 25, 1988·JAMA : the Journal of the American Medical Association·V P Dole
Nov 1, 1987·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·P A Soler InsaA Yotis
Mar 1, 1989·Archives of General Psychiatry·F GawinR Byck
Apr 1, 1986·Pharmacology, Biochemistry, and Behavior·J W WrightJ W Harding
Sep 1, 1984·Archives of General Psychiatry·F H Gawin, H D Kleber
Jul 1, 1995·Addictive Behaviors·M D RobinsonH J Norton
Sep 5, 1995·European Journal of Pharmacology·P Hyytiä, G F Koob
Jun 1, 1995·Drug and Alcohol Dependence·H R KranzlerV Klinghoffer
Jun 1, 1995·Drug and Alcohol Dependence·I D MontoyaD A Gorelick
Jun 1, 1995·Drug and Alcohol Dependence·J W CornishC P O'Brien
Aug 1, 1995·Pharmacology, Biochemistry, and Behavior·S R Tella
May 1, 1995·The American Journal of Psychiatry·S L SatelD S Charney

❮ Previous
Next ❯

Citations

May 23, 2012·Journal of Consulting and Clinical Psychology·Jon MorgensternHenry R Kranzler
Oct 28, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Giovanni AddoloratoAntonello Bonci
Aug 1, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Giorgio GoriniR Dayne Mayfield
Dec 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Philip J RyanAndrew J Lawrence
May 29, 2014·British Journal of Pharmacology·B Jupp, J W Dalley
Jan 25, 2013·Addiction Biology·Judith R HombergMichel M M Verheij
May 8, 2016·Behavioural Brain Research·Flavia Maria SuteraFulvio Plescia
Jul 11, 2016·Neuropharmacology·Hanna E KastmanAndrew J Lawrence
Jul 16, 2016·Behavioural Processes·Christopher A KrebsKaren G Anderson
Jul 28, 2016·Neuroscience and Biobehavioral Reviews·Aurelien BernheimCarmela M Reichel
Jun 19, 2013·European Addiction Research·Roberta AgabioGian Luigi Gessa
May 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Anat MaozRonald G Crystal
Jul 19, 2018·Expert Opinion on Investigational Drugs·Leigh C Walker, Andrew J Lawrence
Feb 28, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alice E BerizziAndrew J Lawrence
Dec 4, 2013·Psychopharmacology·Kenneth A Perkins, Caryn Lerman
May 30, 2012·The Journal of Physiology·Jiann Wei YeohChristopher V Dayas
May 9, 2019·The European Journal of Neuroscience·Leigh C WalkerAndrew J Lawrence
Jul 21, 2017·British Journal of Pharmacology·Leigh C WalkerAndrew J Lawrence
Apr 29, 2020·Alcoholism, Clinical and Experimental Research·Shoupeng WeiJian-Hui Liang
Oct 31, 2019·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Phillipa K ReihanaJulia J Rucklidge
Oct 23, 2013·Pharmacological Reports : PR·Joanna Miszkiel, Edmund Przegaliński
May 21, 2010·Clinical Pharmacology and Therapeutics·K A PerkinsA Jain
Jun 12, 2021·Pharmacology, Biochemistry, and Behavior·Paul W CzotyMichael A Nader

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Alcohol Use Disorder

Alcohol use disorder involves a pattern of alcohol consumption that includes compulsive use and a loss of control over intake of alcohol. The impact on physical health, socioeconomic factors, and psychiatric health is profound. Find the latest research on alcohol use disorder here.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
George F Koob, Michel Le Moal
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
George F Koob, Nora D Volkow
© 2022 Meta ULC. All rights reserved